![Anders Larnholt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anders Larnholt
No open positions remaining
Net worth: 229 979 $ as of 31/07/2026
Profile
Anders Larnholt was the founder of Mallax Pharmaceuticals AB, serving as Head-Mergers & Acquisitions from 2020 to 2022.
Formerly, worked at Meda AB as VP-Corporate Development & Investor Relations from 2010 to 2013.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MedCap AB
 MedCap AB Medical SpecialtiesHealth Technology Manufactures and sells radiological & ECG equipment, probiotics and nutritional supplements 0.03% | 09/02/2026 | 4,000 ( 0.03% ) | 229 979 $ | 31/07/2026 |
Former positions of Anders Larnholt
| Companies | Position | End |
|---|---|---|
Mallax Pharmaceuticals AB
 Mallax Pharmaceuticals AB Financial ConglomeratesFinance Operates as investment company | Founder | 01/12/2022 |
| MEDA AB | Investor Relations Contact | 26/11/2013 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Meda AB
 Meda AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Mallax Pharmaceuticals AB
Mallax Pharmaceuticals AB Financial ConglomeratesFinance Operates as investment company | Finance |
- Stock Market
- Insiders
- Anders Larnholt
